Proteasomal activity in brain differs between species and brain regions and changes with age

Mechanisms of Ageing and Development

Volumn 126, Issue 6-7, 2005, Pages 760-766

  Zeng, B Y ^a   Medhurst, A D ^b   Jackson, M ^a   Rose, S ^a   Jenner, P ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Brain ageing; Proteasomal activity; Species

Indexed keywords

CHYMOTRYPSIN; PROTEASOME; TRYPSIN;

AGED; AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BRAIN REGION; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME ACTIVITY; ENZYME DEGRADATION; FEMALE; FRONTAL CORTEX; GLOBUS PALLIDUS; MARMOSET; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SPECIES COMPARISON; SUBSTANTIA NIGRA;

AGING; ANIMALS; BRAIN; CALLITHRIX; FEMALE; MICE; PARKINSON DISEASE; PROTEASOME ENDOPEPTIDASE COMPLEX; RATS; RATS, SPRAGUE-DAWLEY; SPECIES SPECIFICITY;

ANIMALIA; CALLITHRIX JACCHUS; MARMOSETS; RODENTIA;

EID: 18844418175     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mad.2005.01.008     Document Type: Article

References (49)

1. I. Alkalay, A. Yaron, A. Hatzubai, A. Orian, A. Ciechanover, and Y. Ben-Neriah Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway Proc. Natl. Acad. Sci. U.S.A. 92 1995 10599 10603
2. F. Bardag-Gorce, L. Farout, C. Veyrat-Durebex, Y. Briand, and M. Briand Changes in 20S proteasome activity during ageing of the LOU rat Mol. Biol. Rep. 26 1999 89 93
3. B.C. Braun, M. Glickman, R. Kraft, B. Dahlmann, P.M. Kloetzel, D. Finley, and M. Schmidt The base of the proteasome regulatory particle exhibits chaperone-like activity Nat. Cell Biol. 1 1999 221 226
4. K. Breitschopf, A.M. Zeiher, and S. Dimmeler Ubiquitin-mediated degradation of the proapoptotic active form of bid. A functional consequence on apoptosis induction J. Biol. Chem. 275 2000 21648 21652
5. A.L. Bulteau, K.C. Lundberg, K.M. Humphries, H.A. Sadek, P.A. Szweda, B. Friguet, and L.I. Szweda Oxidative modification and inactivation of the proteasome during coronary occlusion/reperfusion J. Biol. Chem. 276 2001 30057 30063
6. A.L. Bulteau, L.I. Szweda, and B. Friguet Age-dependent declines in proteasome activity in the heart Arch. Biochem. Biophys. 397 2002 298 304
7. J.M. Carney, P.E. Starke-Reed, C.N. Oliver, R.W. Landum, M.S. Cheng, J.F. Wu, and R.A. Floyd Reversal of age-related increase in brain protein oxidation, decrease in enzyme activity, and loss in temporal and spatial memory by chronic administration of the spin-trapping compound N-tert-butyl-alpha-phenylnitrone Proc. Natl. Acad. Sci. U.S.A. 88 1991 3633 3636
8. A. Ciechanover The ubiquitin-proteasome pathway: on protein death and cell life EMBO J. 17 1998 7151 7160
9. M. Conconi, L.I. Szweda, R.L. Levine, E.R. Stadtman, and B. Friguet Age-related decline of rat liver multicatalytic proteinase activity and protection from oxidative inactivation by heat-shock protein 90 Arch. Biochem. Biophys. 331 1996 232 240
10. A. Craiu, M. Gaczynska, T. Akopian, C.F. Gramm, G. Fenteany, A.L. Goldberg, and K.L. Rock Lactacystin and clasto-lactacystin beta-lactone modify multiple proteasome beta-subunits and inhibit intracellular protein degradation and major histocompatibility complex class I antigen presentation J. Biol. Chem. 272 1997 13437 13445
11. K.J. Davies Degradation of oxidized proteins by the 20S proteasome Biochimie 83 2001 301 310
12. G.N. DeMartino, and C.A. Slaughter The proteasome, a novel protease regulated by multiple mechanisms J. Biol. Chem. 274 1999 22123 22126
13. Q. Ding, and J.N. Keller Proteasomes and proteasome inhibition in the central nervous system Free Radical Biol. Med. 31 2001 574 584
14. F. Fornai, P. Lenzi, M. Gesi, M. Ferrucci, G. Lazzeri, C.L. Busceti, R. Ruffoli, P. Soldani, S. Ruggieri, M.G. Alessandri, and A. Paparelli Fine structure and biochemical mechanisms underlying nigrostriatal inclusions and cell death after proteasome inhibition J. Neurosci. 23 2003 8955 8966
15. B. Friguet, A.L. Bulteau, N. Chondrogianni, and M. Conconi Petropoulos. I. Protein degradation by the proteasome and its implications in aging Ann. N. Y. Acad. Sci. 908 2000 143 154
16. B. Friguet, and L.I. Szweda Inhibition of the multicatalytic proteinase (proteasome) by 4-hydroxy-2-nonenal cross-linked protein FEBS Lett. 405 1997 21 25
17. S. Glockzin, A. von Knethen, M. Scheffner, and B. Brune Activation of the cell death program by nitric oxide involves inhibition of the proteasome J. Biol. Chem. 274 1999 19581 19586
18. D.G. Graham Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones Mol. Pharmacol. 14 1978 633 643
19. T. Grune, I.E. Blasig, N. Sitte, B. Roloff, R. Haseloff, and K.J. Davies Peroxynitrite increases the degradation of aconitase and other cellular proteins by proteasome J. Biol. Chem. 273 1998 10857 10862
20. T. Grune, T. Reinheckel, and K.J. Davies Degradation of oxidized proteins in mammalian cells FASEB J. 11 1997 526 534
21. T. Grune, T. Reinheckel, M. Joshi, and K.J. Davies Proteolysis in cultured liver epithelial cells during oxidative stress. Role of the multicatalytic proteinase complex, proteasome J. Biol. Chem. 270 1995 2344 2351
22. A. Ichihara, and K. Tanaka Roles of proteasomes in cell growth Mol. Biol. Rep. 21 1995 49 52
23. M.M. Iravani, K. Kashefi, P. Mander, S. Rose, and P. Jenner Involvement of inducible nitric oxide synthase in inflammation-induced dopaminergic neurodegeneration Neuroscience 110 2002 49 58
24. P. Jenner Oxidative stress in Parkinson's disease Ann. Neurol. 53 Suppl. 3 2003 S26 S36
25. P. Jenner, and C.W. Olanow Understanding cell death in Parkinson's disease Ann. Neurol. 44 Suppl. 1 1998 S72 S84
26. J.N. Keller, K.B. Hanni, and W.R. Markesbery Possible involvement of proteasome inhibition in aging: implications for oxidative stress Mech. Ageing Dev. 113 2000 61 70
27. J.N. Keller, F.F. Huang, and W.R. Markesbery Decreased levels of proteasome activity and proteasome expression in aging spinal cord Neuroscience 98 2000 149 156
28. J.N. Keller, F.F. Huang, H. Zhu, J. Yu, Y.S. Ho, and T.S. Kindy Oxidative stress-associated impairment of proteasome activity during ischemia-reperfusion injury J. Cereb. Blood Flow. Metab. 20 2000 1467 1473
29. J.N. Keller, K.B. Hanni, and W.R. Markesbery Impaired proteasome function in Alzheimer's disease J. Neurochem. 75 2000 436 439
30. M. Lopez-Salon, L. Morelli, E.M. Castano, E.F. Soto, and J.M. Pasquini Defective ubiquitination of cerebral proteins in Alzheimer's disease J. Neurosci. Res. 62 2000 302 310
31. M.J. May, and S. Ghosh Signal transduction through NF-kappa B Immunol. Today 19 1998 80 88
32. K.S. McNaught, and P. Jenner Altered glial function causes neuronal death and increases neuronal susceptibility to 1-methyl-4-phenylpyridinium- and 6-hydroxydopamine-induced toxicity in astrocytic/ventral mesencephalic co-cultures J. Neurochem. 73 1999 2469 2476
33. K.S. McNaught, and P. Jenner Dysfunction of rat forebrain astrocytes in culture alters cytokine and neurotrophic factor release Neurosci. Lett. 285 2000 61 65
34. K.S. McNaught, and P. Jenner Extracellular accumulation of nitric oxide, hydrogen peroxide, and glutamate in astrocytic cultures following glutathione depletion, complex I inhibition, and/or lipopolysaccharide-induced activation Biochem. Pharmacol. 60 2000 979 988
35. K.S. McNaught, and P. Jenner Proteasomal function is impaired in substantia nigra in Parkinson's disease Neurosci. Lett. 297 2001 191 194
36. K.S. McNaught, L.M. Bjorklund, R. Belizaire, O. Isacson, P. Jenner, and C.W. Olanow Proteasome inhibition causes nigral degeneration with inclusion bodies in rats Neuroreport 13 2002 1437 1441
37. K.S. McNaught, R. Belizaire, O. Isacson, P. Jenner, and C.W. Olanow Altered proteasomal function in sporadic Parkinson's disease Exp. Neurol. 179 2003 38 46
38. V.J. Palombella, O.J. Rando, A.L. Goldberg, and T. Maniatis The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B Cell 78 5 1994 773 785
39. G. Paxinos, and C. Watson The Rat Brain in Stereotaxic Coordinates 1986 Academic Press New York
40. T. Reinheckel, N. Sitte, O. Ullrich, U. Kuckelkorn, K.J. Davies, and T. Grune Comparative resistance of the 20S and 26S proteasome to oxidative stress Biochem. J. 335 1998 637 642
41. A.J. Rivett Proteasomes: multicatalytic proteinase complexes Biochem. J. 291 1993 1 10
42. T. Shibatani, M. Nazir, and W.F. Ward Alteration of rat liver 20S proteasome activities by age and food restriction J. Gerontol. 51 1996 316 322
43. N. Sitte, K. Merker, T. Von Zglinicki, K.J. Davies, and T. Grunem Protein oxidation and degradation during cellular senescence of human BJ fibroblasts. Part II. Aging of nondividing cells FASEB J. 14 2000 2503 2510
44. M.B. Spina, and G. Cohen Exposure of striatal [corrected] synaptosomes to L-dopa increases levels of oxidized glutathione J. Pharmacol. Exp. Ther. 247 1988 502 507
45. H. Stephan, G. Baron, and W.K. Schwerdtfeger The Brain of the Common Marmoset: A Sterotactic Atlas 1980 Springer-Verlag Berlin
46. A. Stolzing, and T. Grunem Impairment of protein homeostasis and decline of proteasome activity in microglial cells from adult Wistar rats J. Neurosci. Res. 71 2003 264 271
47. K. Tanaka, and T. Chiba The proteasome: a protein-destroying machine Genes Cells 3 1998 499 510
48. D.C. Tse, R.L. McCreery, and R.N. Adams Potential oxidative pathways of brain catecholamines J. Med. Chem. 19 1976 37 40
49. W.X. Zong, L.C. Edelstein, C. Chen, J. Bash, and C. Gelinas The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis Genes Dev. 13 1999 382 387